Targeted delivery of nano-therapeutics for major disorders of the central nervous system
Major central nervous system (CNS) disorders, including brain tumors, Alzheimer's disease,
Parkinson's disease, and stroke, are significant threats to human health. Although …
Parkinson's disease, and stroke, are significant threats to human health. Although …
Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system
The blood-brain barrier (BBB) is a membrane barrier considered one of the most crucial
protective architectures in the central nervous system (CNS). Its presence acts as a hurdle …
protective architectures in the central nervous system (CNS). Its presence acts as a hurdle …
Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics
Alzheimer's disease (AD) is an irreversible and progressive neurodegenerative disorder
manifested by memory loss and cognitive impairment. Deposition of the amyloid β plaques …
manifested by memory loss and cognitive impairment. Deposition of the amyloid β plaques …
Bioinspired theranostic coordination polymer nanoparticles for intranasal dopamine replacement in Parkinson's disease
Dopamine (DA) is one of the main neurotransmitters found in the central nervous system
and has a vital role in the function of dopaminergic (DArgic) neurons. A progressive loss of …
and has a vital role in the function of dopaminergic (DArgic) neurons. A progressive loss of …
Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson's …
Q Zheng, H Liu, H Zhang, Y Han, J Yuan… - Advanced …, 2023 - Wiley Online Library
Mitochondrial dysfunction of neurons is the core pathogenesis of incurable Parkinson's
disease (PD). It is crucial to ameliorate the mitochondrial dysfunction of neurons for boosting …
disease (PD). It is crucial to ameliorate the mitochondrial dysfunction of neurons for boosting …
Polymeric nanoparticles-based brain delivery with improved therapeutic efficacy of ginkgolide B in Parkinson's disease
Y Zhao, S Xiong, P Liu, W Liu, Q Wang… - International journal …, 2020 - Taylor & Francis
Purpose Ginkgolide B (GB) is a terpene lactone derivative of Ginkgo biloba that is believed
to function in a neuroprotective manner ideal for treating Parkinson's disease (PD). Despite …
to function in a neuroprotective manner ideal for treating Parkinson's disease (PD). Despite …
Development of engineered nanoparticles expediting diagnostic and therapeutic applications across blood–brain barrier
Blood–brain barrier (BBB) is the natural protective tight junctions of epithelial cells that
separate blood vessels from cerebrospinal fluid for protection of brain from various toxic and …
separate blood vessels from cerebrospinal fluid for protection of brain from various toxic and …
Emerging nanotechnology for treatment of Alzheimer's and Parkinson's disease
The prevalence of the two most common neurodegenerative diseases, Parkinson's disease
(PD) and Alzheimer's Disease (AD), are expected to rise alongside the progressive aging of …
(PD) and Alzheimer's Disease (AD), are expected to rise alongside the progressive aging of …
Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson's disease
S Tang, A Wang, X Yan, L Chu, X Yang, Y Song… - Drug Delivery, 2019 - Taylor & Francis
Efficient delivery of brain-targeted drugs is highly important for successful therapy in
Parkinson's disease (PD). This study was designed to formulate borneol and lactoferrin co …
Parkinson's disease (PD). This study was designed to formulate borneol and lactoferrin co …
Increased antiparkinson efficacy of the combined administration of VEGF-and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease
E Herran, C Requejo, JA Ruiz-Ortega… - International Journal …, 2014 - Taylor & Francis
Current research efforts are focused on the application of growth factors, such as glial cell
line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), as …
line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF), as …